References
1. Roger C, Louart B. Beta-Lactams Toxicity in the Intensive Care Unit:
An Underestimated Collateral Damage?. Microorganisms. 2021;9(7):1505.
2. Sutton S, Jumper M, Cook S, Edun B, Wyatt M. Ertapenem-Induced
Encephalopathy in a Patient With Normal Renal Function. Journal of
Investigative Medicine High Impact Case Reports.
2017;5(1):232470961668937.
3. Grill M, Maganti R. Neurotoxic effects associated with antibiotic
use: management considerations. British Journal of Clinical
Pharmacology. 2011;72(3):381-393.
4. Zhang J, Huang C, Li H, Yao Q, Xu J, Yuan J et al.
Antibiotic-induced neurotoxicity in dialysis patients: a retrospective
study. Renal Failure. 2013;35(6):901-905.
5. WALKER A. CONVULSIVE FACTOR IN COMMERCIAL PENICILLIN. Archives of
Surgery. 1945;50(2):69.
6. Barreto E, Webb A, Pais G, Rule A, Jannetto P, Scheetz M. Setting the
Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a
Floor or Even a Ceiling?. Critical Care Explorations. 2021;3(6):e0446.
7. Imani S, Buscher H, Marriott D, Gentili S, Sandaradura I. Too much of
a good thing: a retrospective study of β-lactam concentration–toxicity
relationships. Journal of Antimicrobial Chemotherapy.
2017;72(10):2891-2897.
8. Fugate J, Kalimullah E, Hocker S, Clark S, Wijdicks E, Rabinstein A.
Cefepime neurotoxicity in the intensive care unit: a cause of severe,
underappreciated encephalopathy. Critical Care. 2013;17(6).
9. Bhattacharyya S, Darby R, Raibagkar P, Gonzalez Castro L, Berkowitz
A. Antibiotic-associated encephalopathy. Neurology. 2016;86(10):963-971.
10. Chatellier D, Jourdain M, Mangalaboyi J, Ader F, Chopin C, Derambure
P et al. Cefepime-induced neurotoxicity: an underestimated complication
of antibiotherapy in patients with acute renal failure. Intensive Care
Medicine. 2001;28(2):214-217.
11. Quinton M, Bodeau S, Kontar L, Zerbib Y, Maizel J, Slama M et al.
Neurotoxic Concentration of Piperacillin during Continuous Infusion in
Critically Ill Patients. Antimicrobial Agents and Chemotherapy.
2017;61(9).
12. Chapuis T, Giannoni E, Majcherczyk P, Chioléro R, Schaller M, Berger
M et al. Prospective monitoring of cefepime in intensive care unit adult
patients. Critical Care. 2010;14(2):R51.
13. Sutter R, Rüegg S, Tschudin-Sutter S. Seizures as adverse events of
antibiotic drugs. Neurology. 2015;85(15):1332-1341.
14. Lee S. Cefepime-induced neurotoxicity. Journal of Neurocritical
Care. 2019;12(2):74-84.
15. Erdman M. Cefepime and Acute Encephalopathy: There’s More to This
Story. Neurocritical Care. 2020;33(3):655-656.
16. Meillier A, Rahimian D. Cefepime-induced encephalopathy with normal
renal function. Oxford Medical Case Reports. 2016;2016(6):118-120.
17. Lamoth F, Buclin T, Pascual A, Vora S, Bolay S, Decosterd L et al.
High Cefepime Plasma Concentrations and Neurological Toxicity in Febrile
Neutropenic Patients with Mild Impairment of Renal Function.
Antimicrobial Agents and Chemotherapy. 2010;54(10):4360-4367.
18. Wallace K. ANTIBIOTIC-INDUCED CONVULSIONS. Critical Care Clinics.
1997;13(4):741-762.